US PTAB IP Litigation
8,574 annotated decisions
Page 174 of 358 · 8,574 total
patent
SEG Solar, Inc. et al. v.--
· IPR2026-00230
SEG Solar and affiliated entities have filed an IPR petition challenging Jinko's 2023 solar‑cell patent, asserting that 18 claims are obvious over multiple Chinese patents and academic papers. The petition lays out detailed claim‑by‑claim mappings to prior art and seeks cancellation under § 318(b).
patent
Apple Inc. v.WeCrevention, Inc.
· IPR2026-00243
Apple has filed a petition for inter‑partes review of WeCrevention’s DRAM patent (U.S. 12,154,652), seeking to invalidate claims 1‑6 on anticipation and obviousness grounds using multiple prior‑art references.
patent
Tesla, Inc. v.Bulletproof Property Management, LLC
· IPR2026-00229
Tesla files an IPR petition seeking to invalidate all 20 claims of a vehicle gear‑selection patent, arguing obviousness over multiple prior‑art references.
patent
Imperative Care, Inc. v.Inari Medical, Inc. et al.
· IPR2026-00215
Imperative Care has filed an IPR petition seeking to invalidate Inari Medical’s 12,239,333 patent covering clot‑removal devices. The petition relies on multiple prior‑art references to argue anticipation and obviousness of the asserted claims. The Board must decide whether to institute the review.
patent
Merck Sharp & Dohme LLC v.Pogona, LLC
· IPR2026-00221
Merck has filed an IPR petition challenging all 19 claims of U.S. Patent 11,058,757, alleging that the pneumococcal vaccine claims are anticipated or obvious in view of Porro, Mekalanos, and Siber. The petition argues examiner error and seeks cancellation of the claims.
patent
Apple Inc. v.TopWire, LLC
· IPR2026-00303
Apple has filed an IPR petition seeking cancellation of all nine claims of TopWire’s ’202 Patent covering a spacer‑connector package‑on‑package structure, alleging obviousness over Chen, Sun, Wu and Furuta references.
patent
Google LLC et al. v.HEADWATER RESEARCH LLC
· IPR2026-00203
Google has filed an IPR petition seeking cancellation of all 21 claims of Headwater's 9,232,403 patent covering a secure MMS-enabled mobile device, arguing obviousness over TS‑23.140, Ogawa, and other references.
patent
QD Oxford UK Limited et al. v.Maybell Quantum Industries, Inc.
· IPR2026-00291
QD Oxford UK has filed an IPR petition seeking cancellation of claims 1‑6, 8, and 17‑19 of U.S. Patent 12,313,320 covering dilution refrigerators. The petition relies on six prior‑art references to argue obviousness and anticipation under §§ 102 and 103.
patent terminated or settled
Datavant, Inc. et al. v.Vigilytics LLC
· IPR2024-00382
Datavant and Vigilytics settled their IPR dispute over a HIPAA‑related patent and jointly moved to terminate the proceeding. The Board was asked to end the case under 35 U.S.C. §317(a).
patent denied
Samsung Electronics Co., Ltd. et al. v.Headwater Research LLC
· IPR2024-00342
Samsung and Google petitioned for a Director Review of the PTAB's denial to institute an IPR against Headwater Research's patent. The Board denied the request, leaving the institution denial in place.
patent denied
Samsung Electronics Co., Ltd. et al. v.Headwater Research LLC
· IPR2024-00342
Samsung and Google filed a second IPR petition challenging all claims of Headwater Research's patent, but the USPTO denied institution based on a post‑filing PO stipulation. The petitioners request Director review, arguing the denial misapplies § 314(a) and threatens broader litigation.
patent
Uber Technologies, Inc. et al. v.Carma Technology, Ltd. et al.
· IPR2026-00308
Uber has filed an IPR petition seeking to invalidate Carma Technology’s ridesharing patent (US 11,017,668) on the basis that its claims are obvious over several prior‑art references. The petition lists two grounds covering all 20 claims and requests institution of the review.
patent
Uber Technologies, Inc. et al. v.Carma Technology, Ltd. et al.
· IPR2026-00306
Uber has filed an IPR petition challenging Carma’s ’138 ride‑sharing patent, asserting that the claims are obvious over existing transport‑sharing systems disclosed in Olmi, Gaspard, Thomas and Wolfe.
patent
Beatbot Technology (USA) Co. Ltd. et al. v.Zodiac Pool Systems LLC
· IPR2026-00201
Beatbot Technology has filed an IPR petition challenging Zodiac Pool Systems' 11,880,207 patent covering autonomous pool cleaning robots. The petition alleges obviousness over several prior‑art references and seeks cancellation of fifteen claims.
patent
Cellco Partnership d/b/a Verizon Wireless et al. v.Fractus, S.A.
· IPR2026-00196
Verizon has filed a petition to invalidate Fractus’s 11,031,677 antenna patent, seeking cancellation of all 20 claims on grounds of obviousness and lack of written description for 4G LTE implementations.
patent
Medtronic, Inc. v.Moskowitz Family LLC
· IPR2026-00285
Medtronic has filed an IPR petition seeking to invalidate claims of U.S. Patent 10,603,183 covering spinal intervertebral cage devices. The challenger alleges obviousness over prior art references Moskowitz 440, Waugh, and Michelson 019 and argues a priority-chain error that renders the references prior art under §102(b).
patent
Resmed Corp. v.Fractus, S.A.
· IPR2026-00191
Resmed has filed a petition to cancel all 20 claims of Fractus’s ’677 antenna patent, alleging lack of novelty, obviousness, and insufficient written description for 4G standards. The petition relies on prior‑art references Dou, Ciais‑Quadband, Nakano, and Baliarda‑543.
patent
Microsoft Corporation v.Sandpiper CDN, LLC
· IPR2026-00190
Microsoft has filed an IPR petition challenging all 50 claims of Sandpiper CDN’s ’053 patent, asserting obviousness over a suite of CDN‑related prior art. The petition seeks institution of the proceeding and cancellation of the claims.
patent
Ford Motor Company v.AutoConnect Holdings LLC
· IPR2026-00172
Ford Motor Company has filed an IPR petition challenging AutoConnect’s U.S. Pat. 9,147,297, asserting that its vehicle infotainment control claims are obvious over prior‑art systems such as Zancho, Sundaram, and Demeniuk.
patent
Pfizer Inc. v.Pogona, LLC
· IPR2026-00189
Pfizer has filed an IPR petition seeking cancellation of all 19 claims of U.S. Patent 11,058,757 covering pneumococcal conjugate vaccines, arguing that the claims are anticipated or obvious over prior art such as Alexander and Gu, plus extensive epidemiology literature.
patent
Imperative Care, Inc. v.Inari Medical, Inc. et al.
· IPR2026-00169
Imperative Care has filed an IPR petition challenging Inari Medical’s U.S. Patent 12,156,669 covering an endovascular clot‑removal system. The petition asserts anticipation and obviousness over multiple prior‑art references, including Garrison, Goff, Brady, Pons, Schaffer, and Hartley. The Board must decide whether to institute the review.
patent
Ford Motor Company v.AutoConnect Holdings LLC
· IPR2026-00173
Ford Motor Company has filed an IPR petition challenging AutoConnect’s U.S. Patent 9,173,100 covering vehicle network security. The petition argues lack of priority support and obviousness over four prior‑art references. Ford seeks institution and a finding that the claims are unpatentable.
patent
Sarepta Therapeutics, Inc. et al. v.Genzyme Corporation et al.
· IPR2026-00168
Sarepta has filed an IPR petition seeking cancellation of all 21 claims of Genzyme’s ’880 AAV detection patent, asserting obviousness over six prior‑art references. The petition details how each claim is taught by combinations of those references and argues that secondary considerations are irrelevant.
patent
Camel Manufacturing Company, LLC, d/b/a Camel Expeditionary v.DLX Enterprises LLC
· PGR2024-00033
Camel Manufacturing seeks cancellation of DLX Enterprises' ‘496 patent covering rapid‑deployment hub shelters, alleging on‑sale and public‑use bars based on pre‑filing sales and a 2017 exhibition. The petition provides sales invoices, design drawings, and exhibition photos as prior art.
